Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 32 results when searching "Infliximab"

DOCUMENT

07/08/2024 East Region Formulary Committee Minutes

East Region Formulary ERFC Minutes 07 August 2024 Page 1 of 19 East Region Formulary Committee Minutes Date: 07 August 2024 Time: 2.00pm – 4.45pm Location: MS Teams Present: Carla Capaldi ...

FORMULARY DECISION

Infliximab : Remicade

TA383 (SMC 101/04) : For the treatment of ankylosing spondylitis

FORMULARY DECISION

Infliximab : Remicade

TA187 (SMC 364/07) : For the treatment of fistulising, active Crohn's disease.

FORMULARY DECISION

Infliximab : Remicade

TA187 (SMC 448/08) : Treatment of severe, active Crohn' s disease in paediatric patients

FORMULARY DECISION

Infliximab : Remicade

TA329 (SMC 854/13) : Treatment of severely active ulcerative colitis in children and adolescents aged 6 to 17 years who have had an inadequate response to conventional therapy including corticosteroid...

FORMULARY DECISION

Infliximab : Remicade

TA329 (SMC 374/07) : Treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercapt...

FORMULARY DECISION

Infliximab : Remsima

TA329 (SMC 1006/14) : Rheumatoid arthritis: in combination with methotrexate, for the reduction of signs and symptoms as well as improvement in physical function in: adult patients with active disease...